Tetraphase Pharmaceuticals, Inc.
TTPH
TTPH was delisted on the 28th of July, 2020.
91 hedge funds and large institutions have $93.8M invested in Tetraphase Pharmaceuticals, Inc. in 2016 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 30 reducing their positions, and 24 closing their positions.
10% less funds holding
Funds holding: 101 → 91 (-10)
14% less capital invested
Capital invested by funds: $109M → $93.8M (-$14.8M)
17% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 30
38% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 24
68% less call options, than puts
Call options by funds: $139K | Put options by funds: $437K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$5.64M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$2.75M |
| 3 |
AC
Armistice Capital
New York
|
+$2.21M |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$1.66M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$849K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$6.2M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$4.13M |
| 3 |
Millennium Management
New York
|
-$2.69M |
| 4 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
-$2.14M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.4M |
TTPH Hedge Fund Activity: Q2 2016 in Review
91 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q2 2016, worth a combined $93.8M — down 14% from $109M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of TTPH and 15 opened new positions — a net loss of 9 holders — while 30 trimmed existing stakes and 25 added.
The largest buyer was Wellington Management Group, adding an estimated $5.64M. The largest seller was Great Point Partners, cutting an estimated $6.2M.
- 91 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q2 2016, down from 101 in Q1 2016.
- Funds reported $93.8M of Tetraphase Pharmaceuticals, Inc. stock for Q2 2016, down 14% quarter-over-quarter.
- 15 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q2 2016 and 24 closed out, a net change of -9 holders.
- The largest Tetraphase Pharmaceuticals, Inc. buyer in Q2 2016 was Wellington Management Group, an estimated $5.64M added.
- The largest Tetraphase Pharmaceuticals, Inc. seller in Q2 2016 was Great Point Partners, an estimated $6.2M sold.
Based on aggregated 13F filings for Q2 2016.